Evidence map›Paper›PMID 28739882›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Zebrafish B Cell Development without a Pre-B Cell Stage, Revealed by CD79 Fluorescence Reporter Transgenes.

Xingjun Liu, Yue-Sheng Li, Susan A Shinton, Jennifer Rhodes, Lingjuan Tang, Hui Feng, Cicely A Jette, A Thomas Look, Kyoko Hayakawa, Richard R Hardy

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Xingjun LiuFox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0002-7012-7053
Yue-Sheng LiFox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0002-1393-3913
Susan A ShintonFox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0003-2649-1904
Jennifer RhodesFox Chase Cancer Center, Philadelphia, PA 19111.ORCID 0000-0001-7298-1213
Lingjuan TangFox Chase Cancer Center, Philadelphia, PA 19111.
Hui FengThe Center for Cancer Research, Boston University School of Medicine, Boston, MA 02118.ORCID 0000-0003-1318-821X
Cicely A JetteHuntsman Cancer Institute, University of Utah, Salt Lake City, UT 84103; and.
A Thomas LookDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215.
Kyoko HayakawaFox Chase Cancer Center, Philadelphia, PA 19111; Kyoko.Hayakawa@fccc.edu.ORCID 0000-0003-3157-5897
Richard R HardyFox Chase Cancer Center, Philadelphia, PA 19111.
Fox Chase Cancer Center · USBoston University · USDana-Farber Cancer Institute · USUniversity of Utah · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
DNA Sequencing CoreZICHL006229 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI LI, YUE-SHENG · 2017 to 2025
$35.4M
Mechanisms regulating the B lymphopoiesis fetal/adult switchR01AI113320 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI HAYAKAWA, KYOKO · 2015 to 2019
$2.0M
The Role of DLST in LeukemogenesisR56CA215059 · NCI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FENG, HUI · 2017 to 2017
$376k
NCI NIH HHS P30 CA006927NCI NIH HHS R56 CA215059NIAID NIH HHS R01 AI113320
6 · The paper itself

Abstract

CD79a and CD79b proteins associate with Ig receptors as integral signaling components of the B cell Ag receptor complex. To study B cell development in zebrafish, we isolated orthologs of these genes and performed in situ hybridization, finding that their expression colocalized with IgH-μ in the kidney, which is the site of B cell development. CD79 transgenic lines were made by linking the promoter and upstream regulatory segments of CD79a and CD79b to enhanced GFP to identify B cells, as demonstrated by PCR analysis of IgH-μ expression in sorted cells. We crossed these CD79-GFP lines to a recombination activating gene (Rag)2:mCherry transgenic line to identify B cell development stages in kidney marrow. Initiation of CD79:GFP expression in Rag2:mCherry

Indexed as

AnimalsAnimals, Genetically ModifiedB-LymphocytesCD79 AntigensCell DifferentiationCloning, MolecularDNA-Binding ProteinsFish ProteinsGenes, ReporterGreen Fluorescent ProteinsImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsKidneyLymphocyte ActivationPrecursor Cells, B-LymphoidTransgenesCD79 AntigensDNA-Binding ProteinsFish ProteinsGreen Fluorescent ProteinsImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsRAG2 protein, zebrafishZebrafish Proteins

Identifiers

PMID28739882
PMCPMC5563169
OpenAlexW2738199796

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.